Inhibikase Therapeutics

/Inhibikase Therapeutics

Follow-on

Inhibikase Therapeutics

Pharmaceutical

We are a clinical stage pharmaceutical company developing therapeutics for Parkinson’s Disease, or PD, and related disorders that arise inside and outside of the brain.

Symbol

IKT

Last Closing Price
$5.96

Shares
8,000,000

Anticipated Date
June 16, 2021

Underwriters
FORDHAM FINANCIAL MANAGEMENT, INC.

This offering is no longer available

To view the prospectus for Inhibikase Therapeutics, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange